Drug Therapy, Combination

"Drug Therapy, Combination" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Therapy with two or more separate preparations given for a combined effect.

Descriptor ID	D004359
MeSH Number(s)	E02.319.310
Concept/Terms	Drug Therapy, Combination Drug Therapy, Combination Combination Chemotherapy Drug Polytherapy Drug Polytherapies Polytherapies, Drug Polytherapy, Drug Therapy, Combination Drug Chemotherapy, Combination Chemotherapies, Combination Combination Chemotherapies Combination Drug Therapy Combination Drug Therapies Drug Therapies, Combination Therapies, Combination Drug Polychemotherapy Polychemotherapy Polychemotherapies

Below are MeSH descriptors whose meaning is more general than "Drug Therapy, Combination".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Therapeutics [E02]
Drug Therapy [E02.319]
Drug Therapy, Combination [E02.319.310]

Below are MeSH descriptors whose meaning is more specific than "Drug Therapy, Combination".

Drug Therapy, Combination
Antineoplastic Combined Chemotherapy Protocols
Antiretroviral Therapy, Highly Active

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Drug Therapy, Combination" by people in this website by year, and whether "Drug Therapy, Combination" was a major or minor topic of these publications.

Bar chart showing 299 publications over 30 distinct years, with a maximum of 19 publications in 2010 and 2013

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1993	0	3	3
1994	0	4	4
1995	0	2	2
1996	0	3	3
1997	2	3	5
1998	1	5	6
1999	0	3	3
2000	0	5	5
2001	0	4	4
2002	0	4	4
2003	2	13	15
2004	1	9	10
2005	0	15	15
2006	0	15	15
2007	0	9	9
2008	1	11	12
2009	0	18	18
2010	0	19	19
2011	0	18	18
2012	1	14	15
2013	0	19	19
2014	0	13	13
2015	1	15	16
2016	0	8	8
2017	1	14	15
2018	0	10	10
2019	0	11	11
2020	0	11	11
2021	0	6	6
2022	0	5	5

Below are the most recent publications written about "Drug Therapy, Combination" by people in Profiles.

Song J, Mulsant BH, Sanches M, Alexopoulos GS, Marino P, Meyers BS, Rothschild AJ, Voineskos AN, Whyte EM, Flint AJ, Gerretsen P. Residual or re-emergent impaired insight into delusions following remission is unrelated to later relapse during a randomized clinical trial of continuation pharmacotherapy for psychotic depression - The STOP-PD II Study. J Affect Disord. 2023 03 15; 325:29-34.

View in: PubMed
Flint AJ, Bingham KS, Alexopoulos GS, Marino P, Mulsant BH, Neufeld NH, Rothschild AJ, Voineskos AN, Whyte EM, Meyers BS. Predictors of relapse of psychotic depression: Findings from the STOP-PD II randomized clinical trial. J Psychiatr Res. 2023 01; 157:285-290.

View in: PubMed
Clements KM, Kunte PS, Clark MA, Gurewich D, Greenwood BC, Sefton L, Pratt C, Person SD, Wessolossky MA. Uptake of hepatitis C virus treatment in a multi-state Medicaid population, 2013-2017. Health Serv Res. 2022 Dec; 57(6):1312-1320.

View in: PubMed
Rostanski SK, Kvernland A, Liberman AL, de Havenon A, Henninger N, Mac Grory B, Kim AS, Easton JD, Johnston SC, Yaghi S. Infarct on Brain Imaging, Subsequent Ischemic Stroke, and Clopidogrel-Aspirin Efficacy: A Post Hoc Analysis of a Randomized Clinical Trial. JAMA Neurol. 2022 Mar 01; 79(3):244-250.

View in: PubMed
Ajoolabady A, Bi Y, McClements DJ, Lip GYH, Richardson DR, Reiter RJ, Klionsky DJ, Ren J. Melatonin-based therapeutics for atherosclerotic lesions and beyond: Focusing on macrophage mitophagy. Pharmacol Res. 2022 02; 176:106072.

View in: PubMed
Li X, Le W, Lou X, Wang B, Genco CA, Rice PA, Su X. In Vitro Efficacy of Gentamicin Alone and in Combination with Ceftriaxone, Ertapenem, and Azithromycin against Multidrug-Resistant Neisseria gonorrhoeae. Microbiol Spectr. 2021 10 31; 9(2):e0018121.

View in: PubMed
Curtis JR, Palmer JL, Reed GW, Greenberg J, Pappas DA, Harrold LR, Kremer JM. Real-World Outcomes Associated With Methotrexate, Sulfasalazine, and Hydroxychloroquine Triple Therapy Versus Tumor Necrosis Factor Inhibitor/Methotrexate Combination Therapy in Patients With Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2021 08; 73(8):1114-1124.

View in: PubMed
Gill K, Servati N, Flahive J, Fraielli K. Safety and Efficacy of Triple Therapy With Ticagrelor or Prasugrel Versus Clopidogrel After Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction. J Cardiovasc Pharmacol Ther. 2021 11; 26(6):625-629.

View in: PubMed
Rothschild AJ. The Pitfalls of Psychotropic Polypharmacy. J Clin Psychopharmacol. 2021 May-Jun 01; 41(3):227-232.

View in: PubMed
Patel DA, Flint AJ, Rothschild AJ, Whyte EM, Meyers BS, Mulsant BH, Voineskos AN, Marino P, Alexopoulos GS. Pharmacotherapy Prescriptions for Relapse Prevention of Psychotic Depression After Electroconvulsive Therapy. J Clin Psychopharmacol. 2021 Mar-Apr 01; 41(2):196-199.

View in: PubMed

People

Explore

Similar Concepts

Top Journals